CEO Agronomed Pharmaceuticals LLC and Founder of Agri-Kind LLC & Agronomed Biologics LLC
Agronomed Pharmaceuticals LLC is committed to advancing the Medical Cannabis industry with a primary focus on developing and researching products targeted for specific indications for the best medical efficacy. Cannabis contains more than 480 chemical compounds and more than 80 currently known to only exist in the c cannabis plant, some countries such as Israel and Great Britain have been more liberal in allowing or funding cannabis research and are currently at the forefront of the research currently available. It is Agronomed's mission to help the US catch up in cannabis based or infused product development and ultimately become a leader in the national and global release of proven pharmaceutical products containing cannabis compounds. The large number of chemical compounds that can be present in cannabis enables advancements in product efficacy to be best achieved through a combination of the appropriate, non-biased studies of product chemical profiles mapped to patient outcomes for specific ailments in conjunction with continual application and focus on the aspects of biochemistry and bio-genetics to focus the products and studies accordingly.It is our mission to develop effective formulations based on Biochemistry and Bio-Genetics, drive patient based clinical trials needed to improve or refine those formulations, leverage technology to analyze data collected related to patient outcomes and feed that data back into the product development life cycle.